Altimmune ALT announced that the FDA has granted Breakthrough Therapy Designation to its lead pipeline candidate, pemvidutide ...

Breakthrough Therapy Designation is intended to expedite the development and review of medicines that are intended to treat a serious or life-threatening condition and have shown preliminary clinical ...

Steatohepatitis is a condition in which fatty build-ups in the liver cause inflammation and liver damage. Initially, it may be asymptomatic, but people may experience fatigue, abdominal pain, and ...

Steatohepatitis is an advanced stage of fatty liver disease most often caused by heavy alcohol use. While serious, it can also be treated with lifestyle changes. Steatohepatitis is a liver condition ...

Metabolic dysfunction-associated steatohepatitis (MASH), formally known as nonalcoholic steatohepatitis (NASH), is a liver disease that develops when accumulated liver fat causes inflammation and ...

Dan Marino is opening up about his health — and offering reassurance to fans in the process. The NFL Hall of Famer, 64, gives ...

What Is Metabolic Dysfunction-Associated Steatohepatitis? Metabolic dysfunction-associated steatohepatitis, or MASH, is a form of liver disease. MASH occurs when fat accumulates in liver cells. Plenty ...

A computer search of the Pathology files of Saint Louis University Health Sciences Center from June 1997 to April 2000 for the specific diagnosis of “steatohepatitis” was performed. This file included ...

Nonalcoholic steatohepatitis (NASH) is a form of non-alcohol-related fatty liver disease. It is a chronic condition that can cause lasting damage to the liver. Non-alcohol-related fatty liver disease ...